EQS-News: First CNS Lymphoma Patient Dosed in Phase I/II PTT101 Study with Yttrium (90Y) Anditixafortide (PentixaTher)

EQS-News: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Study First CNS Lymphoma Patient Dosed in Phas...

Related Keywords

Berlin ,Germany ,Hakim Bouterfa ,Eckert Ziegler Strahlen ,Karolin Riehle ,Eckert Ziegler ,University Hospital In Essen ,University Hospital ,Clinicaltrials Gov ,Chief Medical Officer ,